Cao W, Duan H, Shao C, Yan X, et al. Achieving an Objective Response Following Two Cycles of Neoadjuvant Chemotherapy Plus Anti-PD-(L)1 Inhibitors Might Predict the Optimal Pathological Response in Resectable Stage II-III Nonsmall Cell Lung Cancer. Clin Lung Cancer 2025 Aug 9:S1525-7304(25)00178.
PMID: 40908234